Vanda Pharmaceuticals Inc.
NASDAQ:VNDA · NASDAQ Global Market
-$0.20 today
Vol 1.57M · Avg 1.29M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+29.75%
Period High
$9.56
Period Low
$4.19
Latest
$5.80
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Capricor Therapeutics, Inc.
NASDAQ:CAPR
$1.29B
Achieve Life Sciences, Inc.
NASDAQ:ACHV
$504.57M
Allogene Therapeutics, Inc.
NASDAQ:ALLO
$484.08M
Atea Pharmaceuticals, Inc.
NASDAQ:AVIR
$343.72M
Entrada Therapeutics, Inc.
NASDAQ:TRDA
$265.53M
Voyager Therapeutics, Inc.
NASDAQ:VYGR
$222.97M
Sagimet Biosciences Inc.
NASDAQ:SGMT
$217.16M
Arcturus Therapeutics Holdings Inc.
NASDAQ:ARCT
$211.33M
Immuneering Corporation
NASDAQ:IMRX
$156.43M
Humacyte, Inc.
NASDAQ:HUMA
$152.88M
What is the latest VNDA filing?
The latest filing shown is 4 dated Jun 8, 2026.
How many recent filings does VNDA have?
Intrinsic Alpha currently shows 20 recent filings for VNDA.
Explore More
Continue the stock analysis
Jump to another research area for this company.